Josh Horowitz

VC Investor. Passionate about Cybersecurity, BioTech & Cannabis

Follow Josh Horowitz on Social


Analysis: With Oceansix Agreement Signed, Alkemy Faces a Bright Future

With its innovative technology, Alkemy is addressing a significant global environmental challenge and the company has global ambitions as a result

This Platform Is Harnessing AI To Treat Diabetes

Dreamed's Endodigital treats diabetes patients through algorithms

Why this Canadian-Israeli Stock Grew 121% This Year

Innocan Pharma operates three primary and distinct segments: research and development (R&D) of CBD-loaded exosomes, R&D of the use of CBD-loaded liposomes, and commercialization and sale of branded CBD-integrated pharmaceutical and topical treatment products

Story Of a Rising CEO Of Canadian CBD One-stop-shop

Ayurcann Holdings, led by CEO Igal Sudman, is one of Canada's youngest but most distinguished and nominated cannabis extraction and processing companies. The CEO reveals Ayurcann's 2022 strategic plan to key investors

The Scientists who Cracked Diabetes

Dr. Philip Moshe and Eran Atlas are possibly the most influential duo in the Diabetes world over the past two decades as the developers of the AI algorithms behind Medtronic's artificial pancreas and world's first Endocrinology digital expert

This CEO Brings Cutting-Edge Results in the Oil and Gas Industry

Eco Atlantic Oil & Gas' CEO Gil Holzman is one of the world's most creative and resourceful energy executives that has helped transform petroleum exploration company Eco Atlantic Oil & Gas into a global enterprise developing new projects with prominent partners

An Elite Military Intelligence Unit Veteran Aiming To Reinvent Cyber Security

In an aggressive M&A play of one merger and one acquisition within a single quarter, HUB Security, led by CEO Eyal Moshe, has become one of the most interesting cyber security contenders to watch

From Johnson & Johnson To Israeli Tech Ecosystem

Earlier this year, Richard Serbin joined Canadian-Israeli pharmaceuticals company InnoCan Pharma as a consultant. Now the former Johnson & Johnson Vice President and FDA Counsel is already making a major impact: this month he was a featured speaker with InnoCan's CEO Iris Bincovich at the iCDP Conference in Boston

This Top Health-Tech Executive joins the CBD Pharma Industry and Boosts Shareholder Confidence

Since its founding in 2018, InnoCan Pharma has been capturing headlines with its research and development of smart delivery platforms and leading advisory team. Last year, InnoCan added Peter Bloch, one of the industry's foremost health-tech executives

This Startup is Changing the Way Spinal Cord Injury Is Treated Around the World

Hear from the CEO of NurExone Biologic Ltd, Israel's promising new start-up which aims to utilize innovative Exosome-based technology and smart delivery platforms in order to revolutionize the way spinal cord injury (SCI) is treated around the world

China Establishes Digital Yuan As The Official Coin

Every time a nation or a corporation announces sponsorship of a digital asset, the price skyrockets leaving investors flush with high returns

InnoCan Pharma Launches Trading on OTCQB Venture Market

InnoCan Pharma has officially launched common shares trading on the OTCQB Venture Market, placing the promising pharmaceuticals company in the next stage of its strategic commercialization plan

China Bans Foreign Cryptocurrencies and Backs its National Digital Yuan

Analysts predict that China is boycotting all foreign cryptocurrencies in efforts to promote the use of its official national cryptocurrency Digital Yuan

JustKitchen Expands To Hong Kong, Gets BUY Rating from Beacon Research with a Price Target Of $3

The ghost-kitchen player takes on a multi-national expansion plan and delivers on the promise

What is Next for InnoCan Pharma After Strategic Advisory Board Addition

After adding Johnson & Johnson's former vice-president of corporate development and FDA counsel to its advisory board, InnoCan Pharma's future seems bright, and investors are taking notice

More Authors You Might Like